Skip to main content
Loading

VerImmune Inc

February 27, 2024
Platform for Therapeutics
VerImmune Inc
VerImmune Inc is developing a highly innovative Virus-inspired Particle (ViP™) platform technology that has the potential to treat multiple diseases, with an initial focus on Oncology.
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP